Radiation Oncology

Roger W. Byhardt, MD, FACR Professor of Radiation Oncology, Medical Director, Senator Joseph Andrea Cancer Center and the Alyce and Elmer Kramer Cancer Care Center Department of Radiation Oncology 8701 Watertown Plank Road Milwaukee, WI 53226 (414) 805-4498

Curriculum Vitae

Patient Care Emphases

• Head and Neck Cancer
• Lung Cancer
• General Radiation Oncology

Clinical Practice Locations

• Senator Joseph Andrea Cancer Center, Kenosha, at St. Catherine's Campus of United Healthcare Systems: (262) 577-8206
• The Alyce and Elmer Kraemer Cancer Care Center (262) 306-7735

Education

• Doctor of Medicine, Medical College of Wisconsin, Milwaukee, WI (1968).

Training

• Board Certification, Radiation Oncology, American Board of Radiology (1973).
• Residency Radiation Oncology, St. Joseph Hospital, Denver, CO (1969-1972).
• Internship Radiation Oncology, St. Joseph Hospital, Denver, CO (1968-1969).

Representative Publications (last 5 years)

• McAleer M, Moughan J, Byhardt R, Cox J, Sause W, Komaki R.  Does response to induction chemotherapy predict survival for locally advanced non-small cell lung cancer?  Secondary analysis of RTOG 8804/8808. Available online,  Int J Radiat Oncol Biol Phys June 2009.   
• Sarna L, Swan S, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Byhardt R, Wasserman T.  Clinically Meaningful Differences in Patient Reported Outcomes (PROs) with Amifostine in Combination with Chemoradiation for Locally Advanced Non-small Cell Lung Cancer. An Analysis of RTOG 9801. Int J Radiat Oncol Biol Phys 72(5):1378-1384, 2008.
• Calvin D,  Hammond E., Pajak T, Trotti A, Meredith R, Rotman M, Jones C, Byhardt R, Demas W, Ang,K, Fu, K.  Microvessel Density >= 60 Does Not Predict for Outcome After Radiation Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC): Results of a Prospective, Translational Study from the Radiation Therapy Oncology Group (RTOG) 90-03 Trial. Am J Clin Oncol 30(4):406-419, 2007.
• Gillin, M, Dunning B, Lawton C, Foley D, Byhardt R, Morton G, Baikadi M, Pisansky T, Michalski J, Ibbott G, Lopez, F.  Quality Assurance Methods for the First Radiation Therapy Oncology Group Permanent Prostate Implant Protocol. Brachytherapy 5(3):152-156, 2006. 
• Machtay M, Hsu C, Komaki, R, Sause, W, Swann, S, Langer, C., Byhardt, R,Curran, W.  Effect of Overall Treatment Time on Outcomes After Concurrent Chemoradiation for Locally Advanced Non-Small-Cell Lung Carcinoma: Analysis of the Radiation Therapy Oncology Group (RTOG) Experience. Int J Radiat Onco Biol Phys, 63(3):667-671, 2005.
• Komaki R, Swann S, Ettinger D, Glisson B, Sandler A, Movsas B, Suh J, Byhardt, R. Phase I Study of Thoracic Radiation Dose Escalation with Concurrent Chemotherapy for Patients with Limited Small-Cell Lung Cancer: Report of Radiation Therapy Oncology Group (RTOG) Protocol 97-12. Int J Radiat Onco Biol Phys, 62(2):342-350, 2005.
• Ettinger D, Berkey B, Abrams R, Fontanesi J, Machtay M, Duncan P, Curran W, Byhardt, R.  Study of Paclitaxel, Etoposide, and Cisplatin Chemotherapy Combined with Twice-Daily Thoracic Radiotherapy for Patients with Limited-Stage Small-Cell Lung Cancer: A Radiation Therapy Oncology Group (RTOG) 9609 Phase II Study. J Clin Oncol, 23(22):4991-4998, 2005.
• Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Sarna L, Wasserman T, Byhardt R.   Randomized Trial of Amifostine in Locally Advanced Non-Small-Cell Lung Cancer Patients Receiving Chemotherapy and Hyperfractionated Radiation. Radiation Therapy Oncology Group Trial 98-01. J Clin Oncol. 23(10):2145-2154, 2005.